Argus cut shares of Arcadium Lithium (NYSE:ALTM – Free Report) from a strong-buy rating to a hold rating in a research report released on Thursday,Zacks.com reports.
Several other equities research analysts have also recently weighed in on the company. TD Cowen cut Arcadium Lithium from a “strong-buy” rating to a “hold” rating in a report on Monday, October 14th. B. Riley lowered shares of Arcadium Lithium from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 12th. Piper Sandler raised shares of Arcadium Lithium from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 16th. KeyCorp lowered shares of Arcadium Lithium from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 10th. Finally, UBS Group upgraded shares of Arcadium Lithium to a “hold” rating in a research note on Tuesday, September 3rd. Ten investment analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Arcadium Lithium has an average rating of “Hold” and an average target price of $11.00.
View Our Latest Stock Report on Arcadium Lithium
Arcadium Lithium Trading Down 1.3 %
Arcadium Lithium (NYSE:ALTM – Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.04). The business had revenue of $203.10 million for the quarter, compared to analyst estimates of $263.14 million.
About Arcadium Lithium
Arcadium Lithium plc engages in the production of lithium chemicals products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. It offers battery-grade lithium hydroxide, lithium carbonate, butyllithium and high purity lithium metal for electric vehicles, electronics, agricultural, industrial, greases, polymers, pharmaceutical, battery, and aerospace applications.
Read More
- Five stocks we like better than Arcadium Lithium
- Energy and Oil Stocks Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The How And Why of Investing in Oil Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is MarketRank™? How to Use it
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Arcadium Lithium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadium Lithium and related companies with MarketBeat.com's FREE daily email newsletter.